K Pharma (TSE:4896) Total Current Assets: 円2,890.79 Mil (As of Dec. 2025)


TSE:4896 K Pharma Inc TSE:4896
11 GF Score
Price 円729.00
! 1 Warning Sign
View Full Analysis

What is K Pharma Total Current Assets?

K Pharma TSE:4896 +4.29% 11 Total Current Assets is 円2,890.79 Mil as of Dec. 2025. GuruFocus rates TSE:4896 with a GF Score™ of 11/100. The stock has 1 warning sign investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. K Pharma's total current assets for the quarter that ended in Dec. 2025 was 円2,890.79 Mil.


K Pharma  (TSE:4896) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

K Pharma's Liquidation Value for the quarter that ended in Dec. 2025 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2791.835-1673.785+0.75 * 0+0.5 * 11.252
=1,123.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


K Pharma Total Current Assets Related Terms


K Pharma Total Current Assets Historical Data

* Premium members only.

The historical data trend for K Pharma's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

K Pharma Total Current Assets Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Assets
204.69 1,370.93 3,308.97 2,348.14 2,890.79

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,149.25 1,939.95 1,635.05 2,890.79 2,777.24
TSE:4896
11GF Score
K Pharma Inc TSE:4896
Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

K Pharma Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

K Pharma's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

K Pharma's Total Current Assets for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of 円2,890.79 Mil mean?
K Pharma (TSE:4896) has a Total Current Assets of 円2,890.79 Mil as of Dec. 2025. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for K Pharma and its competitors.
Is K Pharma's Total Current Assets too high?
K Pharma's current Total Current Assets is 円2,890.79 Mil. Overall, K Pharma has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does K Pharma's Total Current Assets compare to VRTX and REGN?
K Pharma's Total Current Assets of 円2,890.79 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Biotechnology company?
A good Total Current Assets depends on the Biotechnology industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for K Pharma and its competitors. K Pharma's current Total Current Assets is 円2,890.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is K Pharma stock overvalued right now?
K Pharma (TSE:4896) has a current Total Current Assets of 円2,890.79 Mil. The current Total Current Assets is 円2,890.79 Mil. K Pharma's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For K Pharma (TSE:4896), the current Total Current Assets is 円2,890.79 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

K Pharma Business Description

Address 7-7-7 Roppongi, Tri-Seven Roppongi 8th Floor, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales, and marketing of pharmaceutical products and regenerative medicine products. It is involved in the study of iPs cells in regenerative medicine to treat neurological conditions such as cerebral infarction and SCI.
11GF Score

Get the complete analysis for TSE:4896

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円729.00
Price